Page last updated: 2024-08-21

adamantane and Crohn Disease

adamantane has been researched along with Crohn Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Kim, JW; Kim, SY	1
Braddock, M; Colombel, JF; Eser, A; Persson, T; Reinisch, W; Rutgeerts, P; Vermeire, S; Vogelsang, H	1
Fitzpatrick, LR; Green, CL; Maines, LW; Smith, CD; Zhuang, Y	1

Reviews

1 review(s) available for adamantane and Crohn Disease

Article	Year
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment. International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21 Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles	2021

Article

Year

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment.

International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21

Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles

2021

Trials

1 trial(s) available for adamantane and Crohn Disease

Article	Year
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study. Inflammatory bowel diseases, 2015, Volume: 21, Issue:10 Topics: Adamantane; Administration, Oral; Adult; Benzamides; Biomarkers; C-Reactive Protein; Crohn Disease; Double-Blind Method; Feces; Female; Humans; Leukocyte L1 Antigen Complex; Male; Middle Aged; Purinergic P2X Receptor Antagonists; Quality of Life; Remission Induction; Severity of Illness Index; Surveys and Questionnaires; Young Adult	2015

Article

Year

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study.

Inflammatory bowel diseases, 2015, Volume: 21, Issue:10

Topics: Adamantane; Administration, Oral; Adult; Benzamides; Biomarkers; C-Reactive Protein; Crohn Disease; Double-Blind Method; Feces; Female; Humans; Leukocyte L1 Antigen Complex; Male; Middle Aged; Purinergic P2X Receptor Antagonists; Quality of Life; Remission Induction; Severity of Illness Index; Surveys and Questionnaires; Young Adult

2015

Other Studies

1 other study(ies) available for adamantane and Crohn Disease

Article	Year
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease. Inflammopharmacology, 2010, Volume: 18, Issue:2 Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Epithelial Cells; Female; Gastrointestinal Agents; Humans; Interleukin-1beta; Leukocytes; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Prednisolone; Pyridines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2010

Article

Year

Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.

Inflammopharmacology, 2010, Volume: 18, Issue:2

Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Epithelial Cells; Female; Gastrointestinal Agents; Humans; Interleukin-1beta; Leukocytes; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Prednisolone; Pyridines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2010